CN103263516B - Medicine for treating cholecystitis - Google Patents

Medicine for treating cholecystitis Download PDF

Info

Publication number
CN103263516B
CN103263516B CN201310209982.0A CN201310209982A CN103263516B CN 103263516 B CN103263516 B CN 103263516B CN 201310209982 A CN201310209982 A CN 201310209982A CN 103263516 B CN103263516 B CN 103263516B
Authority
CN
China
Prior art keywords
parts
medicine
radix
cholecystitis
medicines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310209982.0A
Other languages
Chinese (zh)
Other versions
CN103263516A (en
Inventor
刘硕年
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310209982.0A priority Critical patent/CN103263516B/en
Publication of CN103263516A publication Critical patent/CN103263516A/en
Application granted granted Critical
Publication of CN103263516B publication Critical patent/CN103263516B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicine for treating cholecystitis. The medicine is prepared from the following raw materials in parts by weight: 10-30 parts of pseudo-ginseng, 10-20 parts of hawthorn, 10-25 parts of dried tangerine or orange peel, 10-25 parts of lilac, 15-35 parts of radix bupleuri, 15-35 parts of radix paeoniae alba, 20-35 parts of fructus aurantii, 10-20 parts of elecampane, 10-20 parts of toosendan fruit, 6-15 parts of oriental wormwood, 20-35 parts of lysimachia christinae hance, and 3-10 parts of liquorice. The medicine for treating cholecystitis disclosed by the invention comprises radix bupleuri, radix paeoniae alba, fructus aurantii and lysimachia christinae hance as main medicines and other auxiliary medicines matched with the main medicines; all the medicines are influenced each other and synergistically take effect, therefore, the functions of well soothing liver-gallbladder, regulating vital energy, dehumidifying, promoting qi circulation, relieving pain, digesting and relieving dyspepsia are played; for acute and chronic cholecystitis, the medicine has good curative effect; furthermore, the medicine disclosed by the invention is simple in raw material, treats both symptoms and causes, and is low in cost and convenient to take.

Description

A kind of medicine for the treatment of cholecystitis
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of medicine for the treatment of cholecystitis.
Background technology
Cholecystitis is the gallbladder inflammatory lesion that bacterial infection or chemical irritation (bile component change) cause, is the commonly encountered diseases of gallbladder.In abdominal surgery, its sickness rate is only second to appendicitis, and primary disease is more common in the middle age of 35~55 years old, and women's morbidity is many compared with male, is especially more common in the women of obesity and multiple pregnancies.The medicament categories for the treatment of cholecystitis is numerous at present, for example publication number is: CN102988885A, name is called the Chinese invention patent application that mono-kind of < < treats cholecystitis Chinese medicine > >, this Patent Application Publication a kind of cholecystitis Chinese medicine for the treatment of, it is comprised of following traditional Chinese medicines and weight: Herba Artemisiae Scopariae 9-15 gram (12 grams), Rhizoma Dioscoreae 10-17 gram (15 grams), Caulis Bambusae In Taenia 6-15 gram (12 grams), Radix Bupleuri 3-10 gram (9 grams), Radix Scutellariae 3-10 gram (9 grams), Rhizoma Pinelliae Preparata 5-10 gram (9 grams), Radix Curcumae 6-12 gram (10 grams), Endothelium Corneum Gigeriae Galli 3-12 gram (10 grams), Fructus Gardeniae 6-12 gram (10 grams), Semen Arecae 6-10 gram (8 grams), Fructus Hordei Germinatus 6-12 gram (8 grams), Caulis Akebiae 6-12 gram (10 grams), Radix Glycyrrhizae 3-10 gram (6 grams), Semen Coicis 10-25 gram (15 grams).It is reasonable that the present invention treats cholecystitis Chinese medicine formula, and preparation is simple, taking convenience, and curative effect is reliable, and the property of medicine is flat closes, and has no side effect, and through clinical application for many years checking, effective percentage reaches 85%, and cure rate reaches 75%.But the material combination too complex of this medicine.
Summary of the invention
The technical problem to be solved in the present invention is to provide the medicine of simpler, with low cost, the eutherapeutic treatment cholecystitis of a kind of compatibility.
For solving the problems of the technologies described above, the present invention by the following technical solutions:
The present invention treats the medicine of cholecystitis, is to be made by the raw material of following weight proportioning:
Radix Notoginseng 10~30, Fructus Crataegi 10~20, Pericarpium Citri Reticulatae 10~25, Flos Caryophylli 10~25, Radix Bupleuri 15~35, the Radix Paeoniae Alba 15~35, Fructus Aurantii 20~35, the Radix Aucklandiae 10~20, Fructus Toosendan 10~20, Herba Artemisiae Scopariae 6~15, Herba Lysimachiae 20~35, Radix Glycyrrhizae 3~10.
The preferred weight proportioning of each raw material is:
Radix Notoginseng 15~25, Fructus Crataegi 12~18, Pericarpium Citri Reticulatae 15~20, Flos Caryophylli 15~20, Radix Bupleuri 20~30, the Radix Paeoniae Alba 20~30, Fructus Aurantii 25~30, the Radix Aucklandiae 12~18, Fructus Toosendan 12~18, Herba Artemisiae Scopariae 8~12, Herba Lysimachiae 25~30, Radix Glycyrrhizae 4~8.
The optimum weight proportioning of each raw material is:
Radix Notoginseng 20, Fructus Crataegi 15, Pericarpium Citri Reticulatae 18, Flos Caryophylli 18, Radix Bupleuri 25, the Radix Paeoniae Alba 25, Fructus Aurantii 28, the Radix Aucklandiae 15, Fructus Toosendan 15, Herba Artemisiae Scopariae 10, Herba Lysimachiae 28, Radix Glycyrrhizae 6.
The preparation method that the present invention treats the medicine of cholecystitis is: take by weight ratio raw material Radix Notoginseng, Fructus Crataegi, Pericarpium Citri Reticulatae, Flos Caryophylli, Radix Bupleuri, the Radix Paeoniae Alba, Fructus Aurantii, the Radix Aucklandiae, Fructus Toosendan, Herba Artemisiae Scopariae, Herba Lysimachiae, Radix Glycyrrhizae, add the decocting of 8~12 times of raw material weights to boil, after water boils, slow fire boils 30~50 minutes, leach medicinal liquid, obtain.
It is principal agent that the medicine that the present invention treats cholecystitis be take Radix Bupleuri, the Radix Paeoniae Alba, Fructus Aurantii, Herba Lysimachiae, other accessory drugs of arranging in pairs or groups, they influence each other, synergism, thereby play good depressed liver-energy dispersing and function of gallbladder promoting, the dehumidifying of regulating the flow of vital energy, promoting the circulation of QI to relieve pain, help digestion, the effect of stomach function regulating intestinal stasis relieving, for acute and chronic cholecystitis, all have good curative effect, and its raw material is simple, treating both the principal and secondary aspects of a disease, with low cost, taking convenience.
The specific embodiment
With embodiment, the invention will be further described below, but the present invention is not limited to these embodiment.
Umber described in following embodiment is weight portion.
Embodiment 1
Drug weight proportioning:
10 parts of Radix Notoginseng, 10 parts of Fructus Crataegis, 10 parts of Pericarpium Citri Reticulataes, 10 parts of Flos Caryophyllis, 15 parts of Radix Bupleuri, 15 parts of the Radix Paeoniae Albas, 20 parts of Fructus Aurantiis, 10 parts of the Radix Aucklandiae, 10 parts of Fructus Toosendans, 6 parts of Herba Artemisiae Scopariaes, 20 parts of Herba Lysimachiaes, 3 parts, Radix Glycyrrhizae.
Preparation method:
By above-mentioned weight proportion, take raw material, add the decocting of 8 times of raw material weights to boil, after water boils, slow fire boils 30 minutes, leaches medicinal liquid, obtains.
Embodiment 2
Drug weight proportioning:
30 parts of Radix Notoginseng, 20 parts of Fructus Crataegis, 25 parts of Pericarpium Citri Reticulataes, 25 parts of Flos Caryophyllis, 35 parts of Radix Bupleuri, 35 parts of the Radix Paeoniae Albas, 35 parts of Fructus Aurantiis, 20 parts of the Radix Aucklandiae, 20 parts of Fructus Toosendans, 15 parts of Herba Artemisiae Scopariaes, 35 parts of Herba Lysimachiaes, 10 parts, Radix Glycyrrhizae.
Preparation method:
By above-mentioned weight proportion, take raw material, add the decocting of 12 times of raw material weights to boil, after water boils, slow fire boils 50 minutes, leaches medicinal liquid, obtains.
Embodiment 3
Drug weight proportioning:
20 parts of Radix Notoginseng, 15 parts of Fructus Crataegis, 18 parts of Pericarpium Citri Reticulataes, 18 parts of Flos Caryophyllis, 25 parts of Radix Bupleuri, 25 parts of the Radix Paeoniae Albas, 28 parts of Fructus Aurantiis, 15 parts of the Radix Aucklandiae, 15 parts of Fructus Toosendans, 10 parts of Herba Artemisiae Scopariaes, 28 parts of Herba Lysimachiaes, 6 parts, Radix Glycyrrhizae.
Preparation method:
By above-mentioned weight proportion, take raw material, add the decocting of 10 times of raw material weights to boil, after water boils, slow fire boils 40 minutes, leaches medicinal liquid, obtains.
Experimental example:
Below example is further set forth the beneficial effect that the present invention treats the medicine of cholecystitis by experiment.
1, experiment crowd:
Be divided into A, two experimental grouies of B:
A group: cholecystitis patient 100 examples; Male 50 examples wherein, female's 50 examples, 20~40 years old age.
B group: cholecystitis patient 80 examples; Male 25 examples wherein, female's 55 examples, 50~65 years old age.
2, drug administration method:
Medicine every day twice of the treatment cholecystitis that the oral embodiment of the present invention 3 makes, each serving 300 grams, serve on 5 days.
3, efficacy evaluation:
(1) invalid: with take medicine before compare, without significant change.
(2) effective: cholecystitis symptom takes an evident turn for the better.
4, therapeutic effect:

Claims (1)

1. treat a medicine for cholecystitis, it is characterized in that being made by the raw material of following weight proportioning:
Radix Notoginseng 20, Fructus Crataegi 15, Pericarpium Citri Reticulatae 18, Flos Caryophylli 18, Radix Bupleuri 25, the Radix Paeoniae Alba 25, Fructus Aurantii 28, the Radix Aucklandiae 15, Fructus Toosendan 15, Herba Artemisiae Scopariae 10, Herba Lysimachiae 28, Radix Glycyrrhizae 6.
CN201310209982.0A 2013-05-30 2013-05-30 Medicine for treating cholecystitis Expired - Fee Related CN103263516B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310209982.0A CN103263516B (en) 2013-05-30 2013-05-30 Medicine for treating cholecystitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310209982.0A CN103263516B (en) 2013-05-30 2013-05-30 Medicine for treating cholecystitis

Publications (2)

Publication Number Publication Date
CN103263516A CN103263516A (en) 2013-08-28
CN103263516B true CN103263516B (en) 2014-11-26

Family

ID=49007210

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310209982.0A Expired - Fee Related CN103263516B (en) 2013-05-30 2013-05-30 Medicine for treating cholecystitis

Country Status (1)

Country Link
CN (1) CN103263516B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101745071A (en) * 2008-12-03 2010-06-23 袁丽霞 Medicine for treating cholecystitis
CN101766783A (en) * 2008-12-26 2010-07-07 北京中泰天和科技有限公司 Traditional Chinese medicine combination for treating cholecystitis and capsule preparation method thereof
CN102727837A (en) * 2012-07-23 2012-10-17 鲁道宗 Traditional Chinese medicine prescription for treating cholelithiasis and chronic cholecystitis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101745071A (en) * 2008-12-03 2010-06-23 袁丽霞 Medicine for treating cholecystitis
CN101766783A (en) * 2008-12-26 2010-07-07 北京中泰天和科技有限公司 Traditional Chinese medicine combination for treating cholecystitis and capsule preparation method thereof
CN102727837A (en) * 2012-07-23 2012-10-17 鲁道宗 Traditional Chinese medicine prescription for treating cholelithiasis and chronic cholecystitis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
《胆囊术后综合征辩证论治概况》;郑翔等;《甘肃中医》;20091231;第22卷(第8期);第79-81页 *
郑翔等.《胆囊术后综合征辩证论治概况》.《甘肃中医》.2009,第22卷(第8期),第79-81页. *

Also Published As

Publication number Publication date
CN103263516A (en) 2013-08-28

Similar Documents

Publication Publication Date Title
CN101693102A (en) Traditional Chinese medicine compound for treating diseases of incoordination between the spleen and the stomach and abdominal fullness and distention and preparation method thereof
CN103933468A (en) Traditional Chinese medicine for treating acute pancreatitis
CN103381266B (en) Traditional Chinese medicine for treating nervous vomiting
CN103585591A (en) Traditional Chinese medicine for treating gallstones
CN101983644A (en) Medicament for treating sequelae of apoplexy
CN101804189B (en) Drug for treating primary dysmenorrhea
CN103550643A (en) Traditional Chinese medicine for treating tuberculosis
CN103479947B (en) The preparation method of control constipation medicine
CN102940820B (en) Traditional Chinese medicine composition for treating diarrhea
CN103845620A (en) Traditional Chinese medicine for treating raynaud disease
CN103720981A (en) Traditional Chinese medicine for treating dysentery
CN102366602A (en) Traditional Chinese medicine formula used for treating rheumatism
CN103263516B (en) Medicine for treating cholecystitis
CN101502597B (en) Medicament for treating stomachache and preparation method thereof
CN102302744B (en) Chinese medicinal preparation for treating chronic cholecystitis
CN104800799A (en) Traditional Chinese medicament for treating endometrial thickening with ovarian cysts
CN104971302A (en) Traditional Chinese medicine composition for treating biliary tract ascariasis
CN104435545A (en) Traditional Chinese medicine preparation for treating leucopenia caused by benzene poisoning
CN103479952A (en) Summer-heat relieving soup
CN103816493B (en) A kind of Chinese medicine composition treating instability of kidney QI
CN103705629B (en) A kind of Chinese medicine composition for the treatment of pruritus
CN103028058B (en) Traditional Chinese medicine composition for treating feebleness
CN102631633B (en) Preparation method for traditional Chinese medicine wash lotion for treating constipation type acute lymphangitis
CN101229255A (en) Chinese traditional medicine formulation for treating acute waist injury
CN105106913A (en) Traditional Chinese medicine composition for treating spleen-kidney yang deficiency type chronic colitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20141126

Termination date: 20150530

EXPY Termination of patent right or utility model